These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33256158)

  • 1.
    Roh KB; Ryu DH; Cho E; Weon JB; Park D; Kweon DH; Jung E
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33256158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.
    Coda AB; Hata T; Miller J; Audish D; Kotol P; Two A; Shafiq F; Yamasaki K; Harper JC; Del Rosso JQ; Gallo RL
    J Am Acad Dermatol; 2013 Oct; 69(4):570-7. PubMed ID: 23871720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin.
    Lee JB; Bae SH; Moon KR; Na EY; Yun SJ; Lee SC
    Exp Dermatol; 2016 Dec; 25(12):956-961. PubMed ID: 27315464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
    Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
    Front Immunol; 2021; 12():609615. PubMed ID: 34322115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin.
    Kanada KN; Nakatsuji T; Gallo RL
    J Invest Dermatol; 2012 May; 132(5):1435-42. PubMed ID: 22336948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.
    Kim JY; Kim YJ; Lim BJ; Sohn HJ; Shin D; Oh SH
    Yonsei Med J; 2014 Nov; 55(6):1648-55. PubMed ID: 25323904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea.
    Salzer S; Kresse S; Hirai Y; Koglin S; Reinholz M; Ruzicka T; Schauber J
    J Dermatol Sci; 2014 Dec; 76(3):173-9. PubMed ID: 25306296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.
    Thibaut de Ménonville S; Rosignoli C; Soares E; Roquet M; Bertino B; Chappuis JP; Defoin-Platel/Chaussade C; Piwnica D
    Dermatol Ther (Heidelb); 2017 Jun; 7(2):213-225. PubMed ID: 28243927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid.
    Morizane S; Yamasaki K; Kabigting FD; Gallo RL
    J Invest Dermatol; 2010 May; 130(5):1297-306. PubMed ID: 20090765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free adipose tissue extracts as a novel treatment for rosacea by downregulating TRPV1.
    Zhou L; Chen L; Li T; Wang L; Lin S; Zhao Y; Wu S; Jin T
    Sci Rep; 2024 Sep; 14(1):21759. PubMed ID: 39294294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.
    Yamasaki K; Kanada K; Macleod DT; Borkowski AW; Morizane S; Nakatsuji T; Cogen AL; Gallo RL
    J Invest Dermatol; 2011 Mar; 131(3):688-97. PubMed ID: 21107351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.
    Yamasaki K; Di Nardo A; Bardan A; Murakami M; Ohtake T; Coda A; Dorschner RA; Bonnart C; Descargues P; Hovnanian A; Morhenn VB; Gallo RL
    Nat Med; 2007 Aug; 13(8):975-80. PubMed ID: 17676051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coptis chinensis Franch. extract up-regulate type I helper T-cell cytokine through MAPK activation in MOLT-4 T cell.
    Kim E; Ahn S; Rhee HI; Lee DC
    J Ethnopharmacol; 2016 Aug; 189():126-31. PubMed ID: 27224239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.
    Chen M; Xie H; Chen Z; Xu S; Wang B; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Li J; Deng Z
    Biomed Pharmacother; 2019 Aug; 116():109011. PubMed ID: 31132668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New insights in the pathogenesis and treatment of rosacea].
    Palatsi R; Kelhälä HL; Hägg P
    Duodecim; 2012; 128(22):2327-35. PubMed ID: 23342479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immune Dysfunction in Rosacea Promotes Photosensitivity and Vascular Adhesion Molecule Expression.
    Kulkarni NN; Takahashi T; Sanford JA; Tong Y; Gombart AF; Hinds B; Cheng JY; Gallo RL
    J Invest Dermatol; 2020 Mar; 140(3):645-655.e6. PubMed ID: 31472105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Human Kallikrein 5 Protease by Triterpenoids from Natural Sources.
    Matsubara Y; Matsumoto T; Koseki J; Kaneko A; Aiba S; Yamasaki K
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29077044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermasence refining gel modulates pathogenetic factors of rosacea in vitro.
    Borelli C; Becker B; Thude S; Fehrenbacher B; Isermann D
    J Cosmet Dermatol; 2017 Dec; 16(4):e31-e36. PubMed ID: 28349651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal proteases in the pathogenesis of rosacea.
    Meyer-Hoffert U; Schröder JM
    J Investig Dermatol Symp Proc; 2011 Dec; 15(1):16-23. PubMed ID: 22076323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea.
    Deng Z; Chen M; Liu Y; Xu S; Ouyang Y; Shi W; Jian D; Wang B; Liu F; Li J; Shi Q; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Zhang H; Wang Q; Sun L; Xie H; Li J
    EMBO Mol Med; 2021 May; 13(5):e13560. PubMed ID: 33734592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.